VivoSim Labs Statistics
Total Valuation
VivoSim Labs has a market cap or net worth of $4.25 million. The enterprise value is $2.89 million.
| Market Cap | 4.25M |
| Enterprise Value | 2.89M |
Important Dates
The next estimated earnings date is Friday, November 6, 2026, after market close.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VivoSim Labs has 14.85 million shares outstanding. The number of shares has increased by 83.42% in one year.
| Current Share Class | 14.85M |
| Shares Outstanding | 14.85M |
| Shares Change (YoY) | +83.42% |
| Shares Change (QoQ) | +98.74% |
| Owned by Insiders (%) | 2.33% |
| Owned by Institutions (%) | 0.70% |
| Float | 14.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 37.92 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 25.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.70
| Current Ratio | 1.70 |
| Quick Ratio | 0.90 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -944.25 |
Financial Efficiency
Return on equity (ROE) is -343.10% and return on invested capital (ROIC) is -170.03%.
| Return on Equity (ROE) | -343.10% |
| Return on Assets (ROA) | -89.50% |
| Return on Invested Capital (ROIC) | -170.03% |
| Return on Capital Employed (ROCE) | -579.89% |
| Weighted Average Cost of Capital (WACC) | 11.68% |
| Revenue Per Employee | $7,467 |
| Profits Per Employee | -$822,533 |
| Employee Count | 15 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VivoSim Labs has paid $5,000 in taxes.
| Income Tax | 5,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.37% in the last 52 weeks. The beta is 1.47, so VivoSim Labs's price volatility has been higher than the market average.
| Beta (5Y) | 1.47 |
| 52-Week Price Change | -84.37% |
| 50-Day Moving Average | 0.67 |
| 200-Day Moving Average | 1.54 |
| Relative Strength Index (RSI) | 30.52 |
| Average Volume (20 Days) | 6,919,325 |
Short Selling Information
The latest short interest is 570,467, so 3.84% of the outstanding shares have been sold short.
| Short Interest | 570,467 |
| Short Previous Month | 48,730 |
| Short % of Shares Out | 3.84% |
| Short % of Float | 3.93% |
| Short Ratio (days to cover) | 0.06 |
Income Statement
In the last 12 months, VivoSim Labs had revenue of $112,000 and -$12.34 million in losses. Loss per share was -$3.77.
| Revenue | 112,000 |
| Gross Profit | -4.08M |
| Operating Income | -11.33M |
| Pretax Income | -12.33M |
| Net Income | -12.34M |
| EBITDA | -11.14M |
| EBIT | -11.33M |
| Loss Per Share | -$3.77 |
Balance Sheet
The company has $1.67 million in cash and $316,000 in debt, with a net cash position of $1.35 million or $0.09 per share.
| Cash & Cash Equivalents | 1.67M |
| Total Debt | 316,000 |
| Net Cash | 1.35M |
| Net Cash Per Share | $0.09 |
| Equity (Book Value) | -2.35M |
| Book Value Per Share | -0.73 |
| Working Capital | 1.33M |
Cash Flow
In the last 12 months, operating cash flow was -$10.10 million and capital expenditures -$23,000, giving a free cash flow of -$10.12 million.
| Operating Cash Flow | -10.10M |
| Capital Expenditures | -23,000 |
| Depreciation & Amortization | 194,000 |
| Net Borrowing | -353,000 |
| Free Cash Flow | -10.12M |
| FCF Per Share | -$0.68 |
Margins
| Gross Margin | n/a |
| Operating Margin | -10,116.96% |
| Pretax Margin | -11,011.61% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VivoSim Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -83.42% |
| Shareholder Yield | -83.42% |
| Earnings Yield | -290.49% |
| FCF Yield | -238.34% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 21, 2025. It was a reverse split with a ratio of 1:12.
| Last Split Date | Mar 21, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
VivoSim Labs has an Altman Z-Score of -138.8 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -138.8 |
| Piotroski F-Score | 2 |